
|Articles|September 24, 2010
- The Column-09-24-2010
- Volume 6
- Issue 17
Safe to Eat
We spoke to Waters about the development of an international food safety training laboratory set to open next year and how this will help specialists meet global standards.
Advertisement
Food safety issues have become paramount in recent years with an increasing burden on government and industry scientists to meet stringent food safety standards. To address this need, Waters Corporation and the University of Maryland, USA have partnered to create an international food safety training laboratory set to open next year. Janet Kelsey spoke to Paul Young and Jim Willis of Waters to find out more.
Articles in this issue
about 16 years ago
Sea water screeningabout 16 years ago
Finding photosynthesisabout 16 years ago
Pest detectionabout 16 years ago
New Mountain acquires Mallinckrodt Bakerabout 16 years ago
Summer Reflections (Part 1)Advertisement
Related to this article

Liquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.

Leon Niezen and Gert Desmet discuss uncertainty-driven LC method development, peak overlap, and moving from in silico to real data.

Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.

Liquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.

Liquid chromatography-mass spectrometry (LC–MS) growth lifts Waters Q3; MOBILion ion mobility buy expands proteomics.

Liquid chromatography–tandem mass spectrometry (LC–MS/MS) measures galactose-1-phosphate in dried blood spots to monitor galactosemia.
Advertisement
Advertisement
Trending on LCGC International
1
AI/ML Now: Toxicity Prediction for Unknown LC–HRMS Features Using Machine Learning
2
LCGC Blog: Building a Career Series That Goes Beyond the Surface
3
Industry Roundup: Waters Posts Strong Third Quarter as LC–MS and Chromatography Consumables Drive Growth, Acquires Ion Mobility Pioneer MOBILion
4
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
5



